噻二唑IRAK4抑制劑
- 专利权人:
- GILEAD SCIENCES; INC.
- 发明人:
- AMMANN, STEPHEN,安曼 史蒂芬,BACON, ELIZABETH M.,贝肯 伊丽莎白 Ｍ,貝肯 伊麗莎白 Ｍ,BRIZGYS, GEDIMINAS,布立基兹 格迪米纳斯,布立基茲 格迪米納斯,CHIN, ELBERT,陈 阿尔伯特,陳 阿爾伯特,CHOU, CHIENHUNG,周 建宏,COTTELL, JEROMY J.,科特尔 杰若米 Ｊ,科特爾 傑若米
- 申请号：
- TW108128659
- 公开号：
- TW202016115A
- 申请日:
- 2019.08.12
- 申请国别(地区):
- TW
- 年份:
- 2020
- 代理人:
- 摘要：
- A compound of Formula (I):pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed。本發明揭示一種式(I)化合物：其醫藥學上可接受之鹽、其氘化類似物、其組合物以及使用其化合物治療疾病之方法。
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Use of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea and analogs for the treatment of cancers associated with genetic abnormalities in platelet derived growth factor receptor alpha
- USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA
- 1- [4-bromo-5- [1-ethyl-7- (methylamino) -2-oxo-1,2-dihydro-1 for cancer treatment associated with genetic abnormalities of platelet derived growth factor receptor alpha Use of, 6-naphthyridin-3-yl] -2-fluorophenyl] -3-phenylurea and analogs
- COMPOSITION ET PROCEDE POUR DELIVRER UN AMPLIFICATEUR/CO-ACTIVATEUR DE LA BMP-2 AFIN D'AMELIORER L'OSTEOGENESE
